As of June 30, 2026, Covivio carries a market capitalization of 7.34B, placing it among publicly traded companies globally. Its enterprise value stands at 23.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.34B |
| Enterprise Value | 23.23B |
Covivio's next confirmed earnings release is scheduled for February 17, 2027.
| Earnings Date | 2/17/2027 |
As of June 30, 2026, Covivio has 443.11M shares outstanding.
| Shares Outstanding | 443.11M |
These figures are as of June 30, 2026.
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.79 |
As of June 30, 2026, Covivio maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.58 |
| Quick Ratio | 0.20 |
| Debt / Equity | 82.47 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 968.00 |
As of the close on October 23, 2026, Covivio's stock has declined approximately 17.27% over the past 52 weeks.
| 52-Week Price Change | -17.27% |
| 50-Day Moving Average | 14.37 |
As of June 30, 2026, Covivio holds 761.68M in cash and equivalents against 11.89B in total debt, resulting in a net debt position of 10.78B. Total book value stands at 9.67B, with working capital of -1.60B providing operational flexibility.
| Cash & Cash Equivalents | 761.68M |
| Total Debt | 11.89B |
| Net Debt | 10.78B |
| Equity (Book Value) | 9.67B |
| Book Value Per Share | 21.82 |
| Working Capital | -1.60B |
Already premium?